Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

27.16
Delayed Data
As of 4:00pm ET
 +0.89 / +3.39%
Today’s Change
25.55
Today|||52-Week Range
35.04
-20.00%
Year-to-Date
Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results
10:47am / TheStreet.com - Paid Partner Content
Frontrunning: December 5
Dec 05 / Investing Channel - Paid Partner Content
Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs
9:08am / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Analysts' Actions -- Autodesk, Aflac, AstraZeneca, Duluth and More
8:15am / TheStreet.com - Paid Partner Content
3 Horrible Stocks for Retirees
Nov 30 / MotleyFool.com - Paid Partner Content
Top Research Reports for Cisco, Merck & MasterCard
Dec 07 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALI...
Nov 28 / Zacks.com - Paid Partner Content
Why AstraZeneca plc Stock Slumped in November
Dec 07 / MotleyFool.com - Paid Partner Content
Eli Lilly Hits 52-Week Low on Poor Data on Alzheimer's Drug
Nov 25 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
Dec 07 / Zacks.com - Paid Partner Content
Markets sustain Trump-mentum; Yahoo deal in doubt; Yuan slides
Nov 10 / CNNMoney.com
8 Uncommon Stocks NWQ Managers Is Buying
Dec 06 / GuruFocus News - Paid Partner Content